Cargando…

Potential and challenges of serotherapy for severe influenza

Detalles Bibliográficos
Autores principales:	Lee, Nelson, Hui, David S C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129656/ https://www.ncbi.nlm.nih.gov/pubmed/28748808 http://dx.doi.org/10.1016/S2213-2600(17)30266-7

Ejemplares similares

Serotherapy of a spontaneous mouse tumour.
por: O'Neill, G. J.
Publicado: (1980)

Paths to the discovery of antivenom serotherapy in France
por: Bochner, Rosany
Publicado: (2016)

Antigangrenous Serotherapy by a Multivalent Serum
Publicado: (1918)

INTRAVENOUS SEROTHERAPY OF WEIL'S DISEASE (SPIROCHÆETOSIS ICTEROHÆMORRHAGICA)
por: Inada, Ryokichi, et al.
Publicado: (1918)

Tolerance to rat monoclonal antibodies. Implications for serotherapy
Publicado: (1986)

Quand les Français redécouvrent la sérothérapie
por: Manus, Jean-Marie
Publicado: (2020)

Emil Behring's Medical Culture: From Disinfection to Serotherapy
por: SIMON, JONATHAN
Publicado: (2007)

110 Broadly neutralizing antibodies for serotherapy and vaccine design
por: Lanzavecchia, Antonio
Publicado: (2014)

Les venins, les animaux venimeux et la serotherapie anti-venimeuse
Publicado: (1907)

ETIOLOGY OF YELLOW FEVER : XII. CHEMOTHERAPY VERSUS SEROTHERAPY IN EXPERIMENTAL INFECTION WITH LEPTOSPIRA ICTEROIDES.
por: Noguchi, Hideyo
Publicado: (1920)

Fludarabine–Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia
por: Salamonowicz-Bodzioch, Małgorzata, et al.
Publicado: (2021)

Decreased glycolipid antigen expression in lymphoma cell variants escaping from anti-glycolipid serotherapy
Publicado: (1983)

Serotherapy of L1210 murine leukaemia--reasons for ineffectiveness of in vivo treatment by L.1 monoclonal antibody.
por: Testorelli, C., et al.
Publicado: (1983)

Low-Dose Serotherapy Improves Early Immune Reconstitution after Cord Blood Transplantation for Primary Immunodeficiencies
por: Lane, Jonathan P., et al.
Publicado: (2014)

The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease
por: Ali, Robert, et al.
Publicado: (2017)

Serotherapy against Voltage-Gated Sodium Channel-Targeting α-Toxins from Androctonus Scorpion Venom
por: Martin-Eauclaire, Marie-France, et al.
Publicado: (2019)

Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia
por: Keogh, Steven J., et al.
Publicado: (2022)

INDUCED RESISTANCE OF THE CENTRAL NERVOUS SYSTEM TO EXPERIMENTAL INFECTION WITH EQUINE ENCEPHALOMYELITIS VIRUS : II. SEROTHERAPY IN WESTERN VIRUS INFECTION
por: Olitsky, Peter K., et al.
Publicado: (1943)

Influence of C. parvum on the effectiveness of passive serotherapy in the control of the EL4 lymphoma in C57BL/6 mice.
por: O'Neill, G. J., et al.
Publicado: (1980)

Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
por: Vercueil, Colin, et al.
Publicado: (2021)

Adjunctive therapies and immunomodulating agents for severe influenza
por: Hui, David S. C., et al.
Publicado: (2013)

Adjunctive therapies and immunomodulatory agents in the management of severe influenza
por: Hui, David S., et al.
Publicado: (2013)

The role of adjuvant immunomodulatory agents for treatment of severe influenza
por: Hui, David S., et al.
Publicado: (2018)

Extracts from the Foreign Medical Press: Yellow Fever Plus Malaria—Methylene-Blue as an Aid to Diagnosis—Widal's Reaction in Malaria—Albuminuria and Diabetes—Splenectomy—On Dysentery in the Tropics and Liver Abscess—Serotherapy in Plague
por: Sutherland, W. D.
Publicado: (1900)

The influenza challenge
por: Nguyen, Tim, et al.
Publicado: (2010)

The Challenge of Predicting Influenza
por: Ramirez, Julio A.
Publicado: (2011)

Antigenic drift and epidemiological severity of seasonal influenza in Canada
por: Chen, Zishu, et al.
Publicado: (2022)

Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral Challenge
por: Saito, Tetsuya, et al.
Publicado: (2021)

Severe influenza treatment guideline
por: Choi, Won Suk, et al.
Publicado: (2014)

Clinical Management of Pandemic 2009 Influenza A(H1N1) Infection
por: Hui, David S., et al.
Publicado: (2010)

Antioxidant Therapy as a Potential Approach to Severe Influenza-Associated Complications
por: Uchide, Noboru, et al.
Publicado: (2011)

Pandemic Influenza Vaccines – The Challenges
por: Haaheim, Lars R., et al.
Publicado: (2009)

The Growing Challenge of Avian Influenza
por: Imperato, Pascal James
Publicado: (2005)

Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges
por: Engler, Renata J.M., et al.
Publicado: (2020)

H7N9 Avian Influenza A Virus and the Perpetual Challenge of Potential Human Pandemicity
por: Morens, David M., et al.
Publicado: (2013)

The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation
por: Winiszewski, Hadrien, et al.
Publicado: (2018)

Cytokine Response Patterns in Severe Pandemic 2009 H1N1 and Seasonal Influenza among Hospitalized Adults
por: Lee, Nelson, et al.
Publicado: (2011)

Next-generation influenza vaccines: opportunities and challenges
por: Wei, Chih-Jen, et al.
Publicado: (2020)

Influenza Vaccines: Successes and Continuing Challenges
por: Becker, Tanja, et al.
Publicado: (2021)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
por: Wright, Peter F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oosgrg4f7426118h317mq2g6gd